Statement of Use

BLUEROCK

BlueRock Therapeutics LP

Trademark/Service Mark Statement of Use

PTO- 1553
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87361159
LAW OFFICE ASSIGNED LAW OFFICE 122
EXTENSION OF USE NO
MARK SECTION
MARK mark
LITERAL ELEMENT BLUEROCK
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION (current)
NAME BlueRock Therapeutics LP
MAILING ADDRESS One Broadway, Fifteenth Floor
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME BlueRock Therapeutics LP
MAILING ADDRESS One Broadway, Fifteenth Floor
CITY Cambridge
STATE Massachusetts
ZIP/POSTAL CODE 02142
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Michael A. Lisi
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE info@bridgeip.net
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
CORRESPONDENCE INFORMATION (proposed)
NAME Michael A. Lisi
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE info@bridgeip.net
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 369.024195
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 001
CURRENT IDENTIFICATION chemical and biological preparations for medical, industrial and scientific use, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of body cells and cells of the immune system of mammals, including human cells; diagnostic preparations for scientific and research use; combinations of cells and materials, namely, reagents, nucleotides, carrier proteins, encapsulation materials, engineered matrix, diagnostic preparations, scaffolds, polymers, tracers, dyes, hydrogels, activating agents, detergents, stabilisers, emulsifiers, oxidants, antioxidants, vitamins, salts, sugars, amino acids, buffers, nucleic acids and viral vectors for biological scientific and research use
GOODS OR SERVICES DELETE ALL ITU GOODS/SERVICES IN THIS CLASS
WEBPAGE URL None Provided
WEBPAGE DATE OF ACCESS None Provided
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Cells for medical or clinical use; kits comprised of cells and pharmaceuticals, namely biologics, antibacterials, antivirals, antifungals, anti-inflammatories, therapeutics, small molecules, immuno-suppressants, immune-modulators, pro-drugs, cytokines, growth factors, nucleic acids and viral vectors for medical or clinical use; therapeutic pharmaceuticals for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; biological preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders
GOODS OR SERVICES DELETE ALL ITU GOODS/SERVICES IN THIS CLASS
WEBPAGE URL None Provided
WEBPAGE DATE OF ACCESS None Provided
INTERNATIONAL CLASS 040
CURRENT IDENTIFICATION Manufacturing services for others in the field of pharmaceuticals
GOODS OR SERVICES DELETE ALL ITU GOODS/SERVICES IN THIS CLASS
WEBPAGE URL None Provided
WEBPAGE DATE OF ACCESS None Provided
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing
GOODS OR SERVICES DELETED FROM THE APPLICATION Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing
GOODS OR SERVICES IN USE IN COMMERCE Biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells
FIRST USE ANYWHERE DATE 11/25/2020
FIRST USE IN COMMERCE DATE 11/25/2020
SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN3-21623410278-20210220 085853941085_._Class_42_s pecimen.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0002.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0004.JPG
SPECIMEN DESCRIPTION Mark in use on manual with instructions for use in clinical trial
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
GOODS OR SERVICES DELETED FROM THE APPLICATION providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
GOODS OR SERVICES IN USE IN COMMERCE Providing medical information; providing a web site featuring medical information
FIRST USE ANYWHERE DATE 02/22/2017
FIRST USE IN COMMERCE DATE 11/25/2020
SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN4-21623410278-20210220 085853941085_._Class_44_s pecimen.pdf
       CONVERTED PDF FILE(S)
       (3 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0006.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\873\611\87361159\xml4\ SOU0007.JPG
SPECIMEN DESCRIPTION Mark in use on manual used in laboratory or clinical trial settings, AND mark in use on applicant's website
WEBPAGE URL http://bluerocktx.com/research-development/publications/
WEBPAGE DATE OF ACCESS 02/18/2021
REQUEST TO DIVIDE NO
PAYMENT SECTION
NUMBER OF CLASSES IN USE 2
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 200
TOTAL AMOUNT 200
SIGNATURE SECTION
DECLARATION SIGNATURE /Michael A. Lisi/
SIGNATORY'S NAME Michael A. Lisi
SIGNATORY'S POSITION Attorney of record, Michigan bar member
DATE SIGNED 02/20/2021
SIGNATORY'S PHONE NUMBER 2482844091
SIGNATURE METHOD Signed directly within the form
FILING INFORMATION
SUBMIT DATE Sat Feb 20 09:25:37 ET 2021
TEAS STAMP USPTO/SOU-XXX.XXX.XXX.XX-
20210220092537537123-8736
1159-77059aef96983f75e66f
bd4197d2a039ef52ae4efa517
fe317d29c5a671fcf123-CC-2
5343862-20210220085853941
085



PTO- 1553
Approved for use through 12/31/2020. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: BLUEROCK(Standard Characters, see http://uspto.report/TM/87361159/mark.png)
SERIAL NUMBER: 87361159


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: BlueRock Therapeutics LP, having an address of
      One Broadway, Fifteenth Floor
      Cambridge, Massachusetts 02142
      United States
      Email: XXXX
Proposed: BlueRock Therapeutics LP, having an address of
      One Broadway, Fifteenth Floor
      Cambridge, Massachusetts 02142
      United States
      Phone:
      Email: XXXX

The owner is submitting the following allegation of use information:

For International Class 001:
Current identification: chemical and biological preparations for medical, industrial and scientific use, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of body cells and cells of the immune system of mammals, including human cells; diagnostic preparations for scientific and research use; combinations of cells and materials, namely, reagents, nucleotides, carrier proteins, encapsulation materials, engineered matrix, diagnostic preparations, scaffolds, polymers, tracers, dyes, hydrogels, activating agents, detergents, stabilisers, emulsifiers, oxidants, antioxidants, vitamins, salts, sugars, amino acids, buffers, nucleic acids and viral vectors for biological scientific and research use

All ITU goods/services in this class are to be deleted


For International Class 005:
Current identification: Cells for medical or clinical use; kits comprised of cells and pharmaceuticals, namely biologics, antibacterials, antivirals, antifungals, anti-inflammatories, therapeutics, small molecules, immuno-suppressants, immune-modulators, pro-drugs, cytokines, growth factors, nucleic acids and viral vectors for medical or clinical use; therapeutic pharmaceuticals for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; biological preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders

All ITU goods/services in this class are to be deleted


For International Class 040:
Current identification: Manufacturing services for others in the field of pharmaceuticals

All ITU goods/services in this class are to be deleted


For International Class 042:
Current identification: Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing

This allegation of use does NOT cover the following goods/services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods/services are permanently deleted: Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing

The mark is in use in commerce on or in connection with the following goods/services listed in either the application or Notice of Allowance or as subsequently modified for this specific class: Biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells
The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 11/25/2020, and first used in commerce at least as early as 11/25/2020, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Mark in use on manual with instructions for use in clinical trial.

Original PDF file:
SPN3-21623410278-20210220 085853941085_._Class_42_s pecimen.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3

Webpage URL: None Provided
Webpage Date of Access: None Provided

For International Class 044:
Current identification: Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

This allegation of use does NOT cover the following goods/services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods/services are permanently deleted: providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

The mark is in use in commerce on or in connection with the following goods/services listed in either the application or Notice of Allowance or as subsequently modified for this specific class: Providing medical information; providing a web site featuring medical information
The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/22/2017, and first used in commerce at least as early as 11/25/2020, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Mark in use on manual used in laboratory or clinical trial settings, AND mark in use on applicant's website.

Original PDF file:
SPN4-21623410278-20210220 085853941085_._Class_44_s pecimen.pdf
Converted PDF file(s) (3 pages)
Specimen File1
Specimen File2
Specimen File3

Webpage URL: http://bluerocktx.com/research-development/publications/
Webpage Date of Access: 02/18/2021

The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information (current):
      Michael A. Lisi
      PRIMARY EMAIL FOR CORRESPONDENCE: info@bridgeip.net
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
      Michael A. Lisi
      PRIMARY EMAIL FOR CORRESPONDENCE: info@bridgeip.net
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 369.024195.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $200 will be submitted with the form, representing payment for the allegation of use for 2 classes.


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.



Signature: /Michael A. Lisi/      Date Signed: 02/20/2021
Signatory's Name: Michael A. Lisi
Signatory's Position: Attorney of record, Michigan bar member
Signatory's Phone: 2482844091
Signature method: Signed directly within the form

PAYMENT: 87361159
PAYMENT DATE: 02/22/2021

Serial Number: 87361159
Internet Transmission Date: Sat Feb 20 09:25:37 ET 2021
TEAS Stamp: USPTO/SOU-XXX.XXX.XXX.XX-202102200925375
37123-87361159-77059aef96983f75e66fbd419
7d2a039ef52ae4efa517fe317d29c5a671fcf123
-CC-25343862-20210220085853941085



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed